Inventor · disambiguated record
Angelo Aguilar
Also filed as: AGUILAR ANGELO
13 granted patents·7 pending applications·131 citations·filing 2012–2022
91Inventor score
Top patents by PatentIndex Score
20 records- 0194US10307407B29H-pyrimido [4,5-B] indoles as BET bromodomain inhibitorsUNIV MICHIGAN REGENTS·Filed 2016·Granted Jun 4, 2019·11 cites·6 claims
- 0294US10253044B29H-pyrimido [4,5-b]indoles and related analogs as BET bromodomain inhibitorsUNIV MICHIGAN REGENTS·Filed 2017·Granted Apr 9, 2019·11 cites·14 claims
- 0394US8691184B2Bcl-2/Bcl-xL inhibitors and therapeutic methods using the sameWANG SHAOMENG·Filed 2012·Granted Apr 8, 2014·42 cites·15 claims
- 0492US9403856B2Bcl-2/Bcl-xL inhibitors and therapeutic methods using the sameUNIV MICHIGAN REGENTS·Filed 2015·Granted Aug 2, 2016·15 cites·2 claims
- 0590US9580430B29H-pyrimido[4,5-B]indoles and related analogs as BET bromodomain inhibitorsUNIV MICHIGAN REGENTS·Filed 2015·Granted Feb 28, 2017·7 cites·18 claims
- 0689US9096625B2BCL-2/BCL-XL inhibitors and therapeutic methods using the sameUNIV MICHIGAN·Filed 2014·Granted Aug 4, 2015·18 cites·18 claims
- 0788US8629141B2Spiro-oxindole MDM2 antagonistsWANG SHAOMENG·Filed 2012·Granted Jan 14, 2014·14 cites·19 claims
- 0884US9745314B2MDM2 inhibitors and therapeutic methods using the sameUNIV MICHIGAN REGENTS·Filed 2015·Granted Aug 29, 2017·6 cites·26 claims
- 0983US11046703B2Small molecule MDM2 protein degradersUNIV MICHIGAN REGENTS·Filed 2019·Granted Jun 29, 2021·2 cites·18 claims
- 1079US10759808B2Monofunctional intermediates for ligand-dependent target protein degradationUNIV MICHIGAN REGENTS·Filed 2017·Granted Sep 1, 2020·2 cites·20 claims
- 1178US11192898B2MDM2 protein degradersUNIV MICHIGAN REGENTS·Filed 2017·Granted Dec 7, 2021·1 cites·7 claims
- 1270US10899738B2Piperidines as menin inhibitorsUNIV MICHIGAN REGENTS·Filed 2017·Granted Jan 26, 2021·1 cites·29 claims
- 1369US11045448B2Piperidines as covalent menin inhibitorsUNIV MICHIGAN REGENTS·Filed 2018·Granted Jun 29, 2021·1 cites·21 claims
- 1461US2022411432A1Mdm2 protein degradersUNIV MICHIGAN REGENTS·Filed 2021·Application pending·0 cites
- 1560US2021309666A1Small molecule mdm2 protein degradersUNIV MICHIGAN REGENTS·Filed 2021·Application pending·0 cites
- 1657US2021002289A1Monofunctional intermediates for ligand-dependent target protein degradationUNIV MICHIGAN REGENTS·Filed 2020·Application pending·0 cites
- 1755US2021198237A1Piperidines as menin inhibitorsUNIV MICHIGAN REGENTS·Filed 2020·Application pending·0 cites
- 1854US2024166647A1Cereblon LigandsUNIV MICHIGAN REGENTS·Filed 2022·Application pending·0 cites
- 1942US2021115018A1Piperidine compounds as covalent menin inhibitorsUNIV MICHIGAN REGENTS·Filed 2019·Application pending·0 cites
- 2041US2021353610A1Small molecule menin inhibitorsUNIV MICHIGAN REGENTS·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Angelo Aguilar files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →